Announcements
- IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
- IMCD publishes convocation for its upcoming Annual General Meeting
- IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
- IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano
- IMCD announces dividend proposal and Supervisory Board nominations for reappointment
- IMCD reports EBITA of EUR 515 million in 2023
- IMCD Australia and New Zealand strengthen its coatings and construction business with the acquisition of ResChem
More ▼
Key statistics
As of last trade IMCD NV (X6D:FRA) traded at 67.00, 1.52% above its post-IPO low of 66.00, set on Jun 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 67.00 |
---|---|
High | 67.00 |
Low | 67.00 |
Bid | 67.00 |
Offer | 68.00 |
Previous close | 66.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 18 2024 07:25 BST.
More ▼